侵入性腦機介面之風險辨識及審查要點淺析

Identification of Risks Associated with Invasive Brain-Computer Interfaces and Reasons for its Ethical Review

Authors

  • 張新慶 (ZHANG Xinqing) 北京協和醫學院 (Peking Union Medical College, CHINA)
  • 王笑農 (WANG Xiaonong) 北京協和醫學院 (Peking Union Medical College, CHINA)

DOI:

https://doi.org/10.24112/ijccpm.212699

Abstract

LANGUAGE NOTE | Document text in Chinese; abstract also in English.

Brain–computer interface (BCI) technology is an emerging disruptive technology, whose potential risks have been exposed in clinical trials and applications. BCI technology has the characteristics of dual use, and the BCI testing process involves unclear or uncertain risks. Therefore, ethics committees should fully review the ethical aspects of BCI trials in clinical settings.

Downloads

Download data is not yet available.

Downloads

Published

2023-12-29

How to Cite

張 新., & 王 笑. (2023). 侵入性腦機介面之風險辨識及審查要點淺析: Identification of Risks Associated with Invasive Brain-Computer Interfaces and Reasons for its Ethical Review. International Journal of Chinese &Amp; Comparative Philosophy of Medicine, 21(2), 147–151. https://doi.org/10.24112/ijccpm.212699

Issue

Vol. 21 No. 2 (2023)

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The CC BY-NC 4.0 license permits use, distribution and reproduction in any medium, provided the original work is properly cited and not used for commercial purposes. Copyright on any article is retained by the author(s) and the publisher(s).